|
Volumn 95, Issue 2, 2002, Pages 228-235
|
Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma
|
Author keywords
Anthracycline containing regimen; Breast carcinoma; Cyclophosphomide, methotrexate, and 5 fluorouracil; Neoadjuvant chemotherapy; Primary chemotherapy; Randomized controlled trial
|
Indexed keywords
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
FLUOROURACIL;
METHOTREXATE;
TAMOXIFEN;
VINCRISTINE;
ADULT;
AGED;
ALOPECIA;
AMENORRHEA;
ARTICLE;
AXILLARY LYMPH NODE;
BLOOD TOXICITY;
BREAST CARCINOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CANCER SURGERY;
CLINICAL TRIAL;
DRUG RESPONSE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LYMPH NODE METASTASIS;
MAJOR CLINICAL STUDY;
MENOPAUSE;
MUCOSA INFLAMMATION;
MULTIVARIATE ANALYSIS;
POSTMENOPAUSE;
POSTOPERATIVE CARE;
PREOPERATIVE TREATMENT;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
CYCLOPHOSPHAMIDE;
EPIRUBICIN;
FEMALE;
FLUOROURACIL;
HUMANS;
LOGISTIC MODELS;
LYMPHATIC METASTASIS;
MENOPAUSE;
METHOTREXATE;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
PROSPECTIVE STUDIES;
VINCRISTINE;
|
EID: 0037099558
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/cncr.10678 Document Type: Article |
Times cited : (6)
|
References (35)
|